The single beneficial outcome of Dr. Fishbein’s ordeal was that Congressional and press questions about Dr. Fauci’s personal financial stakes in the IL-2 drug forced Dr. Fauci to pledge to donate his royalties from the scheme to charity. HHS thereafter changed its royalty policies—a little—limiting royalty payments to contract employees to $150,000 per year, per employee, per patent. In the thirty years since, no member of the media has ever asked Dr. Fauci how much money he made on IL-2, or to which charity, if any, he directed his donations. Nor has Dr. Fauci ever disclosed the extent of his personal stakes or the financial returns from his patents on other NIAID drugs, or the royalty amounts he has rewarded to loyal cronies and underlings at NIAID for the thousands of other new drugs the agency has developed.
Finally, during all of Dr. Fauci’s tenure at NIH, Dr. Zeke Emmanuel was director of the Department of Bioethics (DOB), the ethical oversight board for all of NIH. Emmanuel’s deputy was Tony Fauci’s wife, Christine Grady. In 2012, Grady took over as director of DOB. That department oversees bioethics at clinical trials for all NIH subagencies, including responsibilities for overseeing ethical issues in clinical trials commissioned by her husband, like those for Nevirapine and Proleukin.
Grady acknowledged in an interview with Vogue that she was aware of Tony Fauci’s reputation as a very scary person, upon their first meeting in 1983.59 “Everyone was afraid of [him]. And when I first saw [him] I thought, ‘What are they talking about?’ He’s young, he’s handsome, and doesn’t seem that scary.”
“Dealing with Tony Fauci is like dealing with organized crime,” says Dr. Fishbein. “He’s like the godfather. He has connections everywhere. He’s always got people that he’s giving money to in powerful positions to make sure he gets his way—that he gets what he wants. These connections give him the ultimate power to fix everything, control every narrative, escape all consequence, and sweep all the dirt and all the bodies under the carpet and to terrorize and destroy anyone who crosses him.”
Endnotes
1 Celia Farber, “Out of control: AIDS and the corruption of medical science,” The Free Library, 2006 Harper’s Magazine Foundation (Jul. 7, 2021), https://www.duesberg.com/articles/2006%20Harper’s,%20Farber%20on%20AIDS%20&%20cancer.pdf
2 Interview with Robert F. Kennedy, Jr., February 2021
3 John Solomon, “U.S. knew of AIDS drug concerns,” Associated Press (Dec. 14, 2004), http://www.newmediaexplorer.org/sepp/2004/12/14/africa_nevirapine_for_aids_mothers_us_hid_research_concerns.htm
4 Anthony Brink, The Trouble with Nevirapine (Open Books, 2008), 179
5 Centre for Research on Multinational Corporations (SOMO), “SOMO briefing paper on ethics in clinical trials #1: Examples of unethical trials” (Feb., 2008), https://www.somo.nl/wp-content/uploads/2008/02/Examples-of-unethical-trials.pdf
6 Brink, op. cit.,188
7 Brink, op. cit., 17
8 “Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures—Worldwide, 1997–2000,” Morbidity and Mortality Weekly Report (Jan 5, 2001), https://www.cdc.gov/mmwr//PDF/wk/mm4951.pdf
9 Brooks Jackson, Laura A. Guay, et al., “Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial,” The Lancet (Sep 4, 1999), https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(99)80008-7/fulltext
10 Ibid.
11 Brink, op. cit., 114
12 J. B. Jackson et al, “Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial,” The Lancet, (Sep 4, 1999), https://pubmed.ncbi.nlm.nih.gov/10485720/
13 Brink, 179
14 Westat Division of AIDS Clinical Research Operations and Monitoring Center, Site Visit Report, Pre-Inspection Audit (Mar. 8, 2002), https://justthenews.com/sites/default/files/2020-07/westat_audit.pdf
15 Ibid.
16 Brink, op. cit., 184
17 Ibid.
18 John Solomon, “Orphans in hospice in Nairobi, Kenya, some of the nearly 2 million children under 15 living with HIV/AIDS in sub-Saharan Africa: NIH was warned in ‘02 on AIDS drug for Africa,” Associated Press (Dec 14, 2004)
19 Ibid.
20 Ibid.
21 Brink, op. cit.,186
22 Westat Division of AIDS Clinical Research Operations and Monitoring Center, Site Visit Report, Pre-Inspection Audit,(Mar. 8, 2002), https://justthenews.com/sites/default/files/2020-07/westat_audit.pdf
23 Farber, op. cit.
24 Brink, 179
25 Michael Carter, “Nevirapine: South African govt tries new ploy to avoid providing HIV drug to mothers,” NAM AIDSMAP (Mar 28, 2002), https://www.aidsmap.com/news/mar-2002/nevirapine-south-african-govt-tries-new-ploy-avoid-providing-hiv-drug-mothers
26 Ibid.
27 E-drug, “Nevirapine /MTCT indication withdrawn in USA” (Mar 25, 2002), http://lists.healthnet.org/archive/html/e-drug/2002-03/msg00062.html
28 The National Academies, “Review of the HIVNET 012 Perinatal HIV Prevention Study” (2005), https://www.ncbi.nlm.nih.gov/books/NBK22287/
29 “NIH AIDS Research Chief Rewrote Safety Report-AP,” AHRP (Oct. 26, 2006), https://ahrp.org/nih-aids-research-chief-rewrote-safety-report-ap/
30 Betsy Smith MD, “The HIVNET 012 Safety Review Panel: Primary Objectives, Approach, Findings and Summary to Date” (Jan. 24, 2003), https://childrenshealthdefense.org/wp-content/uploads/betsy-smith-un-redacted-report-01242003.pdf
31 Ibid.
32 George W. Bush’s State of the Union Speech, CNN (Jan. 29, 2003), https://www.cnn.com/2003/ALLPOLITICS/01/28/sotu.transcript/
33 HIVNET 012 Monitoring report, DAIDS, NIAID (March 2003) (unpublished)
34 “Bush Touts AIDS Initiative During Uganda Visit–2003-07-12,” Voice of America News (Oct 30, 2009), https://www.voanews.com/archive/bush-touts-aids-initiative-during-uganda-visit-2003-07-12
35 Keith Alcorn, “Boehringer cuts nevirapine price for developing world,” NAM AIDSMAP (May 15, 2007), https//www.aidsmap.com/news/may-2007/boehringer-cuts-nevirapine-price-developing-world
36 Associated Press, “Docs Worry AIDS Drug Use May Be Halted,” Fox News (Dec 20, 2004), https://www.foxnews.com/story/docs-worry-aids-drug-use-may-be-halted.amp
37 William J. Clinton Presidential Library, “Apology to survivors of the Tuskegee syphilis experiment,” May 2, 2012, YouTube video, https://www.youtube.com/watch?v=F8Kr-0ZE1XY
38 Brynn Holland, “The ‘Father of Modern Gynecology’ Performed Shocking Experiments on Enslaved Women,” HISTORY (Dec 4, 2018), https://www.history.com/news/the-father-of-modern-gynecology-performed-shocking-experiments-on-slaves
39 Barbara Loe Fisher, “Measles Vaccine Experiments on Minority Children Turn Deadly,” National Vaccine Information Center (June, 1996), https://www.nvic.org/nvic-archives/newsletter/vaccinereactionjune1996.aspx
40 Joseph P. Williams, “From Tuskegee to a COVID Vaccine: Diversity and Racism Are Hurdles in Drug Trials,” U.S. News and World Report (Nov 19, 2020), usnews.com/news/health-news/articles/2020-11-19/from-tuskegee-to-covid-diversity-racism-are-hurdles-in-drug-trials
41 Farber, op. cit.
42 Ibid.
43 Ibid.
44 Ibid.
45 John Solomon and Randy Herschaft, “AIDS drugs likely killed test subject,” Associated Press/The Spokesman Review (Dec 16, 2004), https://www.spokesman.com/stories/2004/dec/16/aids-drugs-likely-killed-test-subject/